Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

Creso Pharma hones in on pivotal Asian markets with Singapore and South Korea distribution deals

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has doubled down on Asian markets after agreeing to expand its product range with Singapore-based distribution group Gotro Global.

Thanks to the deal, which expands the pharmaceutical stock’s footprint in Asia, Creso Pharma’s entire Green Goo animal care range is now stocked online through Gotro’s partner company, Happy Town Pets.

In a bid to further boost product visibility, a company-owned direct-to-consumer eCommerce channel is in development, slated to launch later this year.

Creso Pharma believes establishing a presence in Asia is fundamental to revenue growth, with several initiatives teed up to support the company’s expansion in this critical target market.

Expanding footprint in South Korea

In other news, Creso is also boosting its product reach in South Korea, where leading pet food provider Providence Animal Health Korea has agreed to distribute the Green Goo line alongside the Creso Pharma Switzerland animal care products.

The move comes after an early-stage A$217,400 purchase order for Creso’s anibidiol® product suite, underscoring confidence in consumer interest.

Creso is finalising product registration in Korea to support the Green Goo Animal First Aid range, with other products shortlisted for registration in the coming months.

Targeting sales growth in 2023

Creso Pharma CEO and managing director William Lay said the company’s latest initiatives reflected its momentum in the core Asian markets.

“The expanded distribution partnership in Singapore and South Korea provides Creso Pharma with a unique operating platform to drive further sales growth in 2023, with plenty of additional upside through pending product registrations and the recent launch of Sierra Sage Herbs product line into the Taiwanese animal healthcare market,” he stated.

“We look forward to providing additional updates on growth across the Asia markets over the coming months.”

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK